These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33955200)

  • 1. B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis.
    Numajiri H; Kuzumi A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Asano Y; Kazoe Y; Mawatari K; Kitamori T; Yoshizaki A; Sato S
    Arthritis Rheumatol; 2021 Nov; 73(11):2086-2095. PubMed ID: 33955200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
    Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
    Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
    Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
    Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L736-L753. PubMed ID: 38651940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
    Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
    Miura S; Watanabe Y; Saigusa R; Yamashita T; Nakamura K; Hirabayashi M; Miyagawa T; Yoshizaki A; Trojanowska M; Sato S; Asano Y
    Arthritis Res Ther; 2021 May; 23(1):137. PubMed ID: 33964960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma.
    Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T
    J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
    Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
    Front Immunol; 2019; 10():1861. PubMed ID: 31481954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis.
    Kondo M; Suzuki T; Kawano Y; Kojima S; Miyashiro M; Matsumoto A; Kania G; Błyszczuk P; Ross RL; Mulipa P; Del Galdo F; Zhang Y; Distler JHW
    Arthritis Res Ther; 2022 Sep; 24(1):210. PubMed ID: 36050717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hypofunctional
    Yuan X; Qin X; Takemoto K; Zhao J; Sanderson M; Xu X; Zhang Y; Helke KL; Jacobs Wolf B; Guthridge JM; James JA; Zhou X; Assassi S; Feghali-Bostwick C; Wang D; Sun L; Tsao BP
    Ann Rheum Dis; 2024 Sep; ():. PubMed ID: 39299725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
    Toyama T; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Shudo K; Sato S; Kadono T
    J Invest Dermatol; 2016 Feb; 136(2):387-398. PubMed ID: 26967475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.
    Suzuka T; Kotani T; Saito T; Matsuda S; Sato T; Takeuchi T
    Arthritis Res Ther; 2022 Oct; 24(1):228. PubMed ID: 36207753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylate cyclase stimulator reduced the gastrointestinal fibrosis in bleomycin-induced mouse model of systemic sclerosis.
    Yamamoto Y; Okano T; Yamada H; Akashi K; Sendo S; Ueda Y; Morinobu A; Saegusa J
    Arthritis Res Ther; 2021 May; 23(1):133. PubMed ID: 33941248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of 3'5-dimaleamylbenzoic acid and quercetin decrease pulmonary fibrosis in a systemic sclerosis model.
    Reyes-Jiménez E; Ramírez-Hernández AA; Santos-Álvarez JC; Velázquez-Enríquez JM; González-García K; Carrasco-Torres G; Villa-Treviño S; Baltiérrez-Hoyos R; Vásquez-Garzón VR
    Int Immunopharmacol; 2023 Sep; 122():110664. PubMed ID: 37481854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
    Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.